{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:38:16Z","timestamp":1772134696851,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2003,8,24]],"date-time":"2003-08-24T00:00:00Z","timestamp":1061683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1038\/nm924","type":"journal-article","created":{"date-parts":[[2003,8,22]],"date-time":"2003-08-22T15:06:12Z","timestamp":1061564772000},"page":"1202-1208","source":"Crossref","is-referenced-by-count":464,"title":["TGF-\u03b2-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes"],"prefix":"10.1038","volume":"9","author":[{"given":"M\u00e9riam","family":"Belghith","sequence":"first","affiliation":[]},{"given":"Jeffrey A","family":"Bluestone","sequence":"additional","affiliation":[]},{"given":"Samia","family":"Barriot","sequence":"additional","affiliation":[]},{"given":"J\u00e9r\u00f4me","family":"M\u00e9gret","sequence":"additional","affiliation":[]},{"given":"Jean-Fran\u00e7ois","family":"Bach","sequence":"additional","affiliation":[]},{"given":"Lucienne","family":"Chatenoud","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2003,8,24]]},"reference":[{"issue":"suppl. 2","key":"BFnm924_CR1","first-page":"B7","volume":"22","author":"EA Simone","year":"1999","unstructured":"Simone, E.A., Wegmann, D.R. & Eisenbarth, G.S. Immunologic \u201cvaccination\u201d for the prevention of autoimmune diabetes (type 1A). Diabetes Care 22 (suppl. 2), B7\u2013B15 (1999).","journal-title":"Diabetes Care"},{"key":"BFnm924_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev.immunol.19.1.131","volume":"19","author":"JF Bach","year":"2001","unstructured":"Bach, J.F. & Chatenoud, L. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19, 131\u2013161 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm924_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1073\/pnas.91.1.123","volume":"91","author":"L Chatenoud","year":"1997","unstructured":"Chatenoud, L., Thervet, E., Primo, J. & Bach, J.F. Anti-CD3 antibody induces long-term remission of overt autoimmunity in non obese diabetic mice. Proc. Natl. Acad. Sci. USA 91, 123\u2013127 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm924_CR4","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.158.6.2947","volume":"158","author":"L Chatenoud","year":"1997","unstructured":"Chatenoud, L., Primo, J. & Bach, J.F. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158, 2947\u20132954 (1997).","journal-title":"J. Immunol."},{"key":"BFnm924_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/eji.1830200308","volume":"20","author":"C Ferran","year":"1990","unstructured":"Ferran, C. et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur. J. Immunol. 20, 509\u2013515 (1990).","journal-title":"Eur. J. Immunol."},{"key":"BFnm924_CR6","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4049\/jimmunol.142.3.737","volume":"142","author":"R Hirsch","year":"1989","unstructured":"Hirsch, R., Gress, R.E., Pluznik, D.H., Eckhaus, M. & Bluestone, J.A. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J. Immunol. 142, 737\u2013743 (1989).","journal-title":"J. Immunol."},{"key":"BFnm924_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00007890-199102000-00012","volume":"51","author":"L Chatenoud","year":"1991","unstructured":"Chatenoud, L., Legendre, C., Ferran, C., Bach, J.F. & Kreis, H. Corticosteroid inhibition of the OKT3-induced cytokine-related syndrome\u2014dosage and kinetics prerequisites. Transplantation 51, 334\u2013338 (1991).","journal-title":"Transplantation"},{"key":"BFnm924_CR8","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/00007890-198904000-00008","volume":"47","author":"D Abramowicz","year":"1989","unstructured":"Abramowicz, D. et al. Release of tumor necrosis factor, interleukin-2 and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47, 606\u2013608 (1989).","journal-title":"Transplantation"},{"key":"BFnm924_CR9","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/00007890-199006000-00018","volume":"49","author":"R Hirsch","year":"1990","unstructured":"Hirsch, R., Bluestone, J.A., de Nenno, L. & Gress, R.E. Anti-CD3 F(ab\u2032)2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Transplantation 49, 1117\u20131123 (1990).","journal-title":"Transplantation"},{"key":"BFnm924_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/00007890-199909150-00003","volume":"68","author":"ES Woodle","year":"1999","unstructured":"Woodle, E.S. et al. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation 68, 608\u2013616 (1999).","journal-title":"Transplantation"},{"key":"BFnm924_CR11","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1097\/00007890-199912150-00005","volume":"68","author":"PJ Friend","year":"1999","unstructured":"Friend, P.J. et al. Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation 68, 1632\u20131637 (1999).","journal-title":"Transplantation"},{"key":"BFnm924_CR12","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1056\/NEJMoa012864","volume":"346","author":"KC Herold","year":"2002","unstructured":"Herold, K.C. et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692\u20131698 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnm924_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/eji.1830121116","volume":"12","author":"L Chatenoud","year":"1982","unstructured":"Chatenoud, L. et al. Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody. Eur. J. Immunol. 12, 979\u2013982 (1982).","journal-title":"Eur. J. Immunol."},{"key":"BFnm924_CR14","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.4049\/jimmunol.140.11.3766","volume":"140","author":"R Hirsch","year":"1988","unstructured":"Hirsch, R., Eckhaus. M., Auchincloss, H.J.R., Sachs, D.H. & Bluestone, J.A. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J. Immunol. 140, 3766\u20133772 (1988).","journal-title":"J. Immunol."},{"key":"BFnm924_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0167-5699(84)90061-6","volume":"5","author":"L Chatenoud","year":"1984","unstructured":"Chatenoud, L. & Bach, J.F. Antigenic modulation: a major mechanism of antibody action. Immunol. Today 5, 20\u201325 (1984).","journal-title":"Immunol. Today"},{"key":"BFnm924_CR16","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.4049\/jimmunol.169.5.2461","volume":"169","author":"V Szanya","year":"2002","unstructured":"Szanya, V., Ermann, J., Taylor, C., Holness, C. & Fathman, C.G. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169, 2461\u20132465 (2002).","journal-title":"J. Immunol."},{"key":"BFnm924_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.184.2.387","volume":"184","author":"M Asano","year":"1996","unstructured":"Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387\u2013396 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.192.2.303","volume":"192","author":"T Takahashi","year":"2000","unstructured":"Takahashi, T. et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303\u2013310 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR19","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.4049\/jimmunol.162.9.5317","volume":"162","author":"M Itoh","year":"1999","unstructured":"Itoh, M. et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317\u20135327 (1999).","journal-title":"J. Immunol."},{"key":"BFnm924_CR20","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4049\/jimmunol.157.4.1799","volume":"157","author":"E Suri-Payer","year":"1996","unstructured":"Suri-Payer, E., Kehn, P.J., Cheever, A.W. & Shevach, E.M. Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H\/K adenosine triphosphatase-reactive T cells. J. Immunol. 157, 1799\u20131808 (1996).","journal-title":"J. Immunol."},{"key":"BFnm924_CR21","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.4049\/jimmunol.165.6.3105","volume":"165","author":"LA Stephens","year":"2000","unstructured":"Stephens, L.A. & Mason, D. CD25 is a marker for CD4(+) thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25(+) and CD25(\u2212) subpopulations. J. Immunol. 165, 3105\u20133110 (2000).","journal-title":"J. Immunol."},{"key":"BFnm924_CR22","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1084\/jem.169.5.1669","volume":"169","author":"C Boitard","year":"1989","unstructured":"Boitard, C., Yasunami, R., Dardenne, M. & Bach, J.F. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169, 1669\u20131680 (1989).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR23","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/eji.1830250605","volume":"25","author":"F Lepault","year":"1995","unstructured":"Lepault, F., Gagnerault, M.C., Faveeuw, C., Bazin, H & Boitard, C. Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment. Eur. J. Immunol. 25, 1502\u20131507 (1995).","journal-title":"Eur. J. Immunol."},{"key":"BFnm924_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","volume":"12","author":"B Salomon","year":"2000","unstructured":"Salomon, B. et al. B7\/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431\u2013440 (2000).","journal-title":"Immunity"},{"key":"BFnm924_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1034\/j.1600-065X.2001.1820112.x","volume":"182","author":"L Chatenoud","year":"2001","unstructured":"Chatenoud, L., Salomon, B. & Bluestone, J.A. Suppressor T cells \u2013 they're back and critical for the regulation of autoimmunity. Immunol. Rev. 182, 149\u2013163 (2001).","journal-title":"Immunol. Rev."},{"key":"BFnm924_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1074-7613(00)80323-4","volume":"5","author":"DJ Lenschow","year":"1996","unstructured":"Lenschow, D.J. et al. CD28\/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5, 285\u2013293 (1996).","journal-title":"Immunity"},{"key":"BFnm924_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1084\/jem.194.5.629","volume":"194","author":"K Nakamura","year":"2001","unstructured":"Nakamura, K., Kitani, A. & Strober. W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194, 629\u2013639 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR28","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","volume":"10","author":"T Takahashi","year":"1998","unstructured":"Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state. Int. Immunol. 10, 1969\u20131979 (1998).","journal-title":"Int. Immunol."},{"key":"BFnm924_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"AM Thornton","year":"1998","unstructured":"Thornton, A.M. & Shevach, E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287\u2013296 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1084\/jem.20020590","volume":"196","author":"CA Piccirillo","year":"2002","unstructured":"Piccirillo, C.A. et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196, 237\u2013246 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR31","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2337\/diab.47.8.1207","volume":"47","author":"B Wang","year":"1998","unstructured":"Wang, B. et al. Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47, 1207\u20131211 (1998).","journal-title":"Diabetes"},{"key":"BFnm924_CR32","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4049\/jimmunol.145.5.1415","volume":"145","author":"C Lucas","year":"1990","unstructured":"Lucas, C. et al. The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J. Immunol. 145, 1415\u20131425 (1990).","journal-title":"J. Immunol."},{"key":"BFnm924_CR33","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1084\/jem.185.10.1769","volume":"185","author":"F Bridoux","year":"1997","unstructured":"Bridoux, F. et al. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J. Exp. Med. 185, 1769\u20131779 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/hh2201.099415","volume":"89","author":"Z Mallat","year":"2001","unstructured":"Mallat, Z. et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89, 930\u2013940 (2001).","journal-title":"Circ. Res."},{"key":"BFnm924_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1084\/jem.189.2.279","volume":"189","author":"B Seddon","year":"1999","unstructured":"Seddon, B. & Mason, D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC(\u2212) cells and CD4(+)CD8(\u2212) thymocytes. J. Exp. Med. 189, 279\u2013289 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.192.2.295","volume":"192","author":"S Read","year":"2000","unstructured":"Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295\u2013302 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR37","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1084\/jem.188.10.1849","volume":"188","author":"W Chen","year":"1998","unstructured":"Chen, W., Jin, W. & Wahl, S.M. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor \u03b2 (TGF-\u03b2) production by murine CD4+ T cells. J. Exp. Med. 188, 1849\u20131857 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/eji.1830180325","volume":"18","author":"R Yasunami","year":"1988","unstructured":"Yasunami, R. & Bach, J.F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18, 481\u2013491 (1988).","journal-title":"Eur. J. Immunol."},{"key":"BFnm924_CR39","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1084\/jem.183.6.2669","volume":"183","author":"F Powrie","year":"1996","unstructured":"Powrie, F., Carlino J., Leach M.W., Mauze, S. & Coffman, R.L. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J. Exp. Med. 183, 2669\u20132679 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR40","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1084\/jem.20021139","volume":"196","author":"MK Levings","year":"2002","unstructured":"Levings, M.K. et al. Human CD4+CD25+ T suppressor clones profuse transforming growth factor \u03b2, but not interleukin 10 and are distinct from type 1 T regulatory cells. J. Exp. Med. 196, 1335\u20131346 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR41","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.4049\/jimmunol.159.7.3622","volume":"159","author":"BR Ludviksson","year":"1997","unstructured":"Ludviksson, B.R., Ehrhardt, R.O. & Strober, W. TGF-\u03b2 production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J. Immunol. 159, 3622\u20133628 (1997).","journal-title":"J. Immunol."},{"key":"BFnm924_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/intimm\/10.4.371","volume":"10","author":"M Papiernik","year":"1997","unstructured":"Papiernik, M., de Moraes, M.L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: expression of IL-2R \u03b1 chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371\u2013378 (1997).","journal-title":"Int. Immunol."},{"key":"BFnm924_CR43","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.4049\/jimmunol.168.11.5558","volume":"168","author":"L Graca","year":"2002","unstructured":"Graca, L. et al. Both CD4+CD25+ and CD4+CD25\u2212 regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168, 5558\u20135565 (2002).","journal-title":"J. Immunol."},{"key":"BFnm924_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1084\/jem.187.3.427","volume":"187","author":"F Luhder","year":"1998","unstructured":"Luhder, F., Hoglund, P., Allison, J.P., Benoist, C. & Mathis, D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187, 427\u2013432 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm924_CR45","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.4049\/jimmunol.155.3.1544","volume":"155","author":"ML Alegre","year":"1995","unstructured":"Alegre, M.L. et al. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. J. Immunol. 155, 1544\u20131555 (1995).","journal-title":"J. Immunol."},{"key":"BFnm924_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","volume":"1","author":"TL Walunas","year":"1994","unstructured":"Walunas, T.L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405\u2013413 (1994).","journal-title":"Immunity"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm924.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm924","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm924.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:35:07Z","timestamp":1684434907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,24]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["BFnm924"],"URL":"https:\/\/doi.org\/10.1038\/nm924","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1013584.196051","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,24]]}}}